Kadcyla® (ado-trastuzumab emtansine)
for Breast Cancer

Kadcyla (ado-trastuzumab emtansine) is a targeted therapy used to treat HER2-positive breast cancer, including early-stage and metastatic cases. It is typically prescribed after other cancer treatments have been unsuccessful. Kadcyla works by interfering with the growth and spread of cancer cells.

Heart
Other top medicines used to treat Breast Cancer